Our
mission
The fruit of a collaboration between industry and research
The development of Neolys Diagnostics tests is the result of a meeting between industry and radiobiology researchers from Lyon (INSERM unit).
Reliable technology
First of all, our team has developed a reliable technology, based on the implementation of predictive tests, allowing the personalization of radiotherapy treatments.
We are responding to a need: to predict the radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities.
Our
motivation
- Treatment optimization
- Prevention of environmental or medical-related toxicity
- Innovations to broaden our scope
Our team
Our team is mainly composed of professional biology researchers, specialized in radiobiology.
Sandrine Pereira
R&D Director
PhD in radiobiology, Sandrine is also an industrial transfer and medical devices specialist. She supervises the R&D department of the company.
Elise Berthel
R&D Manager - Project Manager
PhD in radiobiology, Elise supervises the company’s research and development unit.
Mirlande Duclos
Laboratory technician
Mirlande takes part in R&D experiments and is specialized in performing radiosensitivity tests.
Patrick Barhoum
Business Developer
Phd in science specialising in chemistry and biology and a master’s degree in innovation management. Patrick is in charge of business development.
Antoine Jehl
Assistant Laboratory Engineer
He participates in the management and organization of the laboratory. It contributes to R&D experiments and radiosensitivity testing.
Louise Eyler
Assistant Laboratory Engineer
With a Master’s degree in Pharmaceutical Sciences, she is involved in R&D experiments and radiosensitivity testing.
Mathilde-Hà LASNON
Production Manager - Laboratory
Biology engineer specializing in in-vitro diagnostics. She oversees the management and organization of the laboratory, while participating in radiosensitivity tests and experiments.
Our partners
